Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology-NTNU, Trondheim, Norway.
Phytother Res. 2011 Jul;25(7):1068-72. doi: 10.1002/ptr.3402.
The aim of the present study was to clarify the in vitro potential of the purified Chinese herbal constituents LZX-A (neferine), QTJ (sinomenine), YHS (tetrahydropalmitine) and SQZG (notoginsenoside R1) to displace the highly bound bilirubin from albumin binding sites in plasma from jaundiced newborn infants. Sulfisoxazole (1.32 mM) was used as a positive control for bilirubin displacement. The displacing potential of the herbal constituents was investigated at assumed therapeutic concentrations and up to 100 times higher. Total (TB) and unbound (UB) bilirubin in plasma were measured by the peroxidase method. Sulfisoxazole increased the UB concentration in plasma by more than 60%. An increased % displacement of bilirubin was found at higher TB levels confirming the presence also of lower affinity binding sites for bilirubin in plasma. None of the purified herbal constituents showed any bilirubin displacing properties and were unaffected by the level of TB in plasma. The combination of sulfisoxazole and the herbal constituents showed no synergistic effect. It is concluded that none of the investigated purified herbal constituents possess any significant potential in vitro to increase the UB concentration in plasma from jaundiced newborn infants.
本研究旨在阐明纯化的中草药成分 LZX-A(小檗碱)、QTJ(盐酸青藤碱)、YHS(四氢巴马汀)和 SQZG(三七皂苷 R1)在体外从黄疸新生儿血浆中高结合胆红素白蛋白结合位点置换的潜在能力。磺胺异恶唑(1.32mM)用作胆红素置换的阳性对照。在假设的治疗浓度和高达 100 倍的浓度下,研究了草药成分的置换潜力。采用过氧化物酶法测定血浆中总胆红素(TB)和未结合胆红素(UB)。磺胺异恶唑使血浆中 UB 浓度增加了 60%以上。在较高的 TB 水平下发现胆红素的置换百分比增加,证实了在血浆中也存在较低亲和力的胆红素结合位点。纯化的中草药成分均未显示出任何胆红素置换特性,并且不受血浆 TB 水平的影响。磺胺异恶唑和中草药成分的组合没有协同作用。结论是,在所研究的纯化中草药成分中,没有任何一种具有显著的体外增加黄疸新生儿血浆 UB 浓度的潜力。